latest news releases from the newsroom
NetManage Announces Results from SOA Legacy Application Modernization Study
CUPERTINO, Calif., Nov. 13, 2006 (PRIMEZONE) -- NetManage, Inc. (Nasdaq:NETM), a software company that provides solutions for integrating, Web enabling and accessing enterprise information systems, today announced results from a Service-oriented architecture (SOA) legacy application modernization study. The study, which was based on an analysis of derivative data from Aberdeen Research's "Legacy Application Modernization Benchmark Report," found that 53 percent of respondents will address legacy modernization and cultural challenges by taking a systematic "incremental" approach to SOA modernization projects in order to ensure project success and meet ROI goals.
Shareholder Vision Releases New Video Profile of ATSI Communications Including An Interview With Company CEO Arthur Smith
DALLAS, Nov. 13, 2006 (PRIMEZONE) -- Ed Newsome, Vice President and Senior Producer of Shareholder Vision, announced today that the web site has released a new video profile of ATSI Communications, Inc. (OTCBB:ATSX). Included in this video profile is an exclusive interview with the company President and CEO Arthur Smith. ATSI Communications is a global Voice over Internet protocol ("VoIP") communications Company based in San Antonio, Texas. The Company operates through its two wholly owned subsidiaries, Digerati Networks, Inc. and Telefamilia Communications, Inc. ATSI also owns a minority interest of a subsidiary in Mexico, ATSI Comunicaciones, S.A. de C.V., which operates under a 30-year government issued telecommunications license similar to those owned by AT&T's and MCI's subsidiaries in Mexico. ATSI is focused on serving high-growth international markets and ethnic communities in the USA. ATSI's primary market, Mexico, is the top producer of voice communications traffic with the U.S., making it the most lucrative telecommunications corridor in the world in terms of revenue. The Company's customer base includes a variety of carriers, including top tier providers and emerging operators that generate communications traffic to and from the markets served by ATSI.
MorphoSys and Boehringer Ingelheim Expand Collaboration With New Cancer-Related Antibody Program
MARTINSRIED, Germany, Nov. 13, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today that its partner Boehringer Ingelheim has exercised an option for optimizing a therapeutic HuCAL antibody and has acquired an exclusive license for this project. The antibody identified by Boehringer Ingelheim at its research site in Vienna is directed against a cancer disease-related target molecule. MorphoSys will optimize the antibody in accordance with the requirements of the partner and will receive additional research payments. Further financial details were not disclosed.
Bodisen Biotech Receives a Letter From American Stock Exchange
SHAANXI, China, Nov. 12, 2006 (PRIMEZONE) -- Bodisen Biotech, Inc. (AMEX:BBC), (LSE:BODI), (www.bodisen.com), today announced that, on November 6, 2006, the Company received a letter from the American Stock Exchange ("Amex") stating that the Staff had determined that the Company was not in compliance with certain of the Amex continued listing standards, specifically Sections 132(a), 132(e), and 403 of the Amex Company Guide, and need to be improved in the future.
Keller Rohrback L.L.P.
Keller Rohrback Announces Investigation of Valeant Pharmaceuticals Intl. for Backdating of Stock Options
SEATTLE, Nov. 10, 2006 (PRIMEZONE) -- Keller Rohrback L.L.P. (www.seattleclassaction.com) today announced that it has commenced an investigation of Valeant Pharmaceuticals International ("Valeant" or the "Company") (NYSE:VRX) and current and former Company executive officers and directors for potential violations related to the backdating of stock options. On September 11, 2006, Valeant announced that it is conducting an internal review of its historical stock option grant practices and is cooperating with the SEC's informal inquiry regarding stock options granted by the Company since January 1, 2000. On October 20, 2006, Valeant's Board of Directors concluded that, based on the preliminary report of the special committee conducting the internal review, options granted in 1997 and "subsequent years" reflected incorrect measurement dates and that correcting these measurement dates would result in restatement of the Company's financial statements for undetermined periods from 1997 to the present. The Company further stated that the special committee's review of Valeant's stock option grant practices and its analysis regarding the magnitude of financial restatements is ongoing.